WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02269 WUXI BIO

Market Closed 03-28 16:08:10

26.800

-0.950

-3.42%

High27.750	Low26.400	Vol67.48M
Open27.550	D1 Closing27.750	Amplitude4.86%
Mkt Cap110.07B	Tradable Cap110.07B	Total Shares4.11B
T/O1.82B	T/O Rate1.64%	Tradable Shares4.11B
P/B2.46	ROE8.82%	EPS0.88
52wk High28.850	52wk Low10.140	P/E30.47
Dividend0.00	Div.Yield0.00	ROA5.05%

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"WUXI BIO","latestPrice":26.8,"timestamp":1743149290011,"preClose":27.75,"halted":0,"volume":67483908,"delay":0,"floatShares":4107000000,"shares":4107000000,"eps":0.8796894411549651,"marketStatus":"Market Closed","change":-0.95,"latestTime":"03-28 16:08:10","open":27.55,"high":27.75,"low":26.4,"amount":1815320461,"amplitude":0.048649,"askPrice":26.8,"askSize":57500,"bidPrice":26.75,"bidSize":162500,"shortable":3,"etf":0,"ttmEps":0.8395647503539257,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743384600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":27.75,"openAndCloseTimeList":[[1743125400000,1743134400000],[1743138000000,1743148800000]],"volumeRatio":1.330342,"optionData":{"bulkOrders":[{"symbol":"WXB.HK","call":true,"expireDate":1745856000000,"strike":"29.00","timestamp":1743147825462,"price":1.11,"volume":277,"amount":153735,"type":"*"}]},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.581,"impliedVolPercentile":0.3429},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2522172349","title":"Greater China Stocks Close Mixed; Hong Kong Leads Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2522172349","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522172349?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 16:30","pubTimestamp":1743064200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Greater China were mixed on Thursday.Among Hang Seng constituents, ENN Energy Holdings Ltd. was the biggest gainer during the session, surging 11%, and Haidilao International Holding Ltd. surged 6.0%. Wuxi Biologics  Inc. rounded out the top three movers on Thursday, as shares surged 5.9%.Xiaomi Corp. posted the largest decline among companies on the Hang Seng, falling 4.2%, followed by shares of Zijin Mining Group Co. Ltd., which fell 3.0%. Shares of Shenzhou International Group Holdings Ltd. fell 1.7%.Among large mainland China stocks, Circuit Fabology Microelectronics Equipment Co. Ltd. A was the biggest gainer during the session, surging 12%, and Mabwell  Bioscience Co. Ltd. A surged 11%. RemeGen Co. Ltd. A rounded out the top three movers on Thursday, as shares surged 11%.In Taiwan, Lung Hwa Electronics Co. Ltd. was the biggest gainer among large companies during the session, s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008368742.USD","IE00B031HY20.USD","BK1583","LU1064131003.USD","IE00BVYPNP33.GBP","HK0000306701.USD","601899","LU1048596156.SGD","BK1591","BK1193","LU0651946864.USD","IE0034224299.USD","IE00B5MMRT66.SGD","81810","LU0039217434.USD","LU0516422366.SGD","688298","02313","LU0348814723.USD","HK0000306685.HKD","02688","XIACY","01810","IE00BPRC5H50.USD","LU0516422952.EUR","BK0012","688630","LU0348735423.USD","BK1592","600105","688062","LU2097828557.USD","LU0181495838.USD","BK0251","LU1770036033.HKD","HK0000320223.HKD","02269","06862","LU0650527681.SGD","LU0499858602.USD","LU0516423174.USD","BK1521","LU0856984785.SGD","BK1233","LU0149534421.HKD","HXXD.SI","603289","LU2289578879.USD","BK1198"],"gpt_icon":1},{"id":"2522202453","title":"BRIEF-WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522202453","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522202453?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 19:48","pubTimestamp":1742903296,"startTime":"0","endTime":"0","summary":"BRIEF-WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025March 25 (Reuters) - WuXi Biologics (Cayman) Inc 2269.HK:WUXI BIOLOGICS FY ADJUSTED NET INCOME RMB 5,396.9 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nPLX410EB6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572944931.SGD","LU0320764599.SGD","LU1720050803.USD","LU2039709279.SGD","BK1521","LU0052750758.USD","LU0348825331.USD","LU0456827905.SGD","LU0516423091.SGD","LU1242518857.USD","LU0326950275.SGD","LU0456846285.SGD","LU0051755006.USD","IE00B0JY6N72.USD","LU0039217434.USD","SG9999002562.SGD","BK1576","LU0181495838.USD","LU0708995583.HKD","LU0359202008.SGD","LU1794554557.SGD","BK1589","LU0043850808.USD","02269","BK1141","LU0516422366.SGD","LU0856984785.SGD","LU0516423174.USD","LU0417516902.SGD","LU0823426308.USD","LU0140636845.USD","LU0359201612.USD","LU0307460666.USD","LU0417516738.SGD","LU0516422440.USD","LU0516422952.EUR","LU1688375341.USD","LU0327786744.USD","LU1880383366.USD","LU1242518931.SGD","BK1610","LU0348735423.USD","LU0819121731.USD","LU0823426480.USD","LU0979878070.USD","SG9999002463.SGD","LU0588546209.SGD"],"gpt_icon":0},{"id":"2522040787","title":"WuXi Biologics' Profit Slides 1.3% in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2522040787","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522040787?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 18:55","pubTimestamp":1742900121,"startTime":"0","endTime":"0","summary":"WuXi Biologics   recorded a 1.3% decline in attributable profit for the year 2024 to 3.36 billion yuan from 3.4 billion yuan in the year-ago period, a Tuesday filing with the Hong Kong bourse said.Earnings per share were 0.78 yuan in the year, up from 0.77 yuan in the previous corresponding year.The vaccine maker's revenue rose by 9.6% to 18.7 billion yuan in the year from 17 billion yuan a year prior.The higher revenue was mainly due to the successful execution of the company's \"Follow and Win the Molecule\" strategies, an enlarged spectrum of services offered to the biologics industry, growth of research services revenue, and the utilization of existing and newly expanded capacities.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0140636845.USD","LU0456846285.SGD","LU1242518857.USD","LU0417516738.SGD","LU1880383366.USD","LU0856984785.SGD","LU0516422366.SGD","LU0456827905.SGD","LU0181495838.USD","BK1521","LU0708995583.HKD","LU0516422952.EUR","BK1576","LU0326950275.SGD","LU0039217434.USD","LU0359201612.USD","LU0516423091.SGD","LU0572944931.SGD","LU0320764599.SGD","LU0516422440.USD","LU0348735423.USD","LU0043850808.USD","BK1610","BK1589","LU0052750758.USD","LU1794554557.SGD","LU0979878070.USD","LU0823426308.USD","LU0417516902.SGD","LU1720050803.USD","LU1242518931.SGD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0588546209.SGD","LU0359202008.SGD","LU0307460666.USD","LU1688375341.USD","SG9999002463.SGD","02269","LU0348825331.USD","SG9999002562.SGD","BK1141","LU0051755006.USD","LU0327786744.USD","LU0516423174.USD","LU0819121731.USD","LU0823426480.USD"],"gpt_icon":1},{"id":"2522601825","title":"BRIEF-WuXi Biologics Posts FY Revenue Of RMB18,675.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522601825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522601825?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 16:45","pubTimestamp":1742892314,"startTime":"0","endTime":"0","summary":"BRIEF-WuXi Biologics Posts FY Revenue Of RMB18,675.4 MlnMarch 25  - WuXi Biologics  Inc 2269.HK:FY REVENUE RMB 18,675.4 MILLIONFY GROSS MARGIN 41%FY NET INCOME RMB 3,945.4 MILLIONFY GROSS PROFIT RMB 7,650.8 MILLIONFurther company coverage: 2269.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nPLXCA4736:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"gpt_icon":0},{"id":"2519272843","title":"WuXi Biologics (Cayman) Inc. (HKG:2269) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable","url":"https://stock-news.laohu8.com/highlight/detail?id=2519272843","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519272843?lang=en_us&edition=full_marsco","pubTime":"2025-03-16 08:30","pubTimestamp":1742085017,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) Inc. ( HKG:2269 ) shares have continued their recent momentum with a 28% gain in the last month...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-inc-hkg2269-stocks-shoot-up-28-but-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0140636845.USD","LU0456846285.SGD","LU1242518857.USD","LU0417516738.SGD","LU1880383366.USD","LU0856984785.SGD","LU0516422366.SGD","LU0456827905.SGD","LU0181495838.USD","BK1521","LU0708995583.HKD","LU0516422952.EUR","BK1576","LU0326950275.SGD","LU0039217434.USD","LU0359201612.USD","LU0516423091.SGD","LU0572944931.SGD","LU0320764599.SGD","LU0516422440.USD","LU0348735423.USD","LU0043850808.USD","BK1610","BK1589","LU0052750758.USD","LU1794554557.SGD","LU0979878070.USD","LU0823426308.USD","LU0417516902.SGD","LU1720050803.USD","LU1242518931.SGD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0588546209.SGD","LU0359202008.SGD","LU0307460666.USD","LU1688375341.USD","SG9999002463.SGD","02269","LU0348825331.USD","SG9999002562.SGD","BK1141","LU0051755006.USD","LU0327786744.USD","LU0516423174.USD","LU0819121731.USD","LU0823426480.USD"],"gpt_icon":1},{"id":"2519829991","title":"Greater China Stocks Close Mixed; Hong Kong Leads Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2519829991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519829991?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 16:30","pubTimestamp":1741941000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Greater China were mixed on Friday.Among Hang Seng constituents, Wuxi Biologics  Inc. was the biggest gainer during the session, surging 14%, and China Mengniu Dairy Co. Ltd. surged 9.0%. New Oriental Education & Technology Group Inc. rounded out the top three movers on Friday, as shares surged 8.1%.CK Hutchison Holdings Ltd. posted the largest decline among companies on the Hang Seng, dropping 6.4%, followed by shares of CK Infrastructure Holdings Ltd., which fell 2.9%. Shares of WH Group Ltd. fell 2.5%.Among large mainland China stocks, Cabio Biotech  Co. Ltd. A was the biggest gainer during the session, surging 18%, and Nanya New Material Technology Co. Ltd. A surged 13%. Nanjing Medlander Medical Technology Co. Ltd. A rounded out the top three movers on Friday, as shares surged 12%.In Taiwan, Billion Electric Co. Ltd. was the biggest gainer among large companies during the sessi","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU0594300419.USD","LU0650527681.SGD","LU0287142896.SGD","BK0226","00001","LU1023057109.AUD","688089","LU0181495838.USD","BK1521","LU0708995583.HKD","LU0543330483.HKD","688273","BK1576","LU0326950275.SGD","BK0279","LU0348788117.USD","603958","IE00B031J352.USD","LU0359201612.USD","02319","SG9999001069.SGD","603206","BK1603","LU0228367735.SGD","688519","BK0000","BK1589","LU0979878070.USD","IE0032834883.USD","SGXZ90724238.SGD","LU0417516902.SGD","LU1720050803.USD","00288","LU1051768304.USD","LU1242518931.SGD","IE0009570106.USD","600967","LU1048588211.SGD","IE00B0JY6N72.USD","LU0702159699.USD","SG9999002463.SGD","02269","SG9999001226.SGD","BK0188","LU0672654166.SGD","01038","BK1569","LU0819121731.USD","LU0048580855.USD"],"gpt_icon":1},{"id":"2518753572","title":"WuXi Biologics Included in S&P Global Sustainability Yearbook 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2518753572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518753572?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 11:18","pubTimestamp":1741663137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nTUA51980W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02269","LU1880383366.USD","LU1496350171.SGD","BK4566","LU0979878070.USD","BK1589","LU2720916845.USD","LU0181495838.USD","LU2023251221.USD","LU2210149790.SGD","SG9999014880.SGD","LU0354030511.USD","LU1496350502.SGD","IE00B19Z9505.USD","IE00B0JY6N72.USD","LU1633808545.USD","LU1242518857.USD","LU2264538146.SGD","LU0516423091.SGD","LU1989764748.USD","LU0320764599.SGD","BK4112","LU0823426480.USD","LU0985320562.USD","LU0097036916.USD","BK4581","BK4534","SG9999014906.USD","SG9999002463.SGD","LU1989773731.SGD","GB00BDT5M118.USD","LU0158827948.USD","LU0417516738.SGD","LU1242518931.SGD","LU2265009873.SGD","BK1521","SG9999017495.SGD","LU0868494617.USD","LU2028103732.USD","LU0345774631.USD","LU0823426308.USD","LU2271345857.HKD","SPGI","LU0348825331.USD","LU0140636845.USD","LU1720050803.USD","LU0516423174.USD","LU0039217434.USD","LU2764262908.HKD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2517959369","title":"WuXi Biologics (Cayman) Inc.'s (HKG:2269) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517959369","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517959369?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 07:58","pubTimestamp":1741132715,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) (HKG:2269) has had a great run on the share market with its stock up by a significant 34% over...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-incs-hkg2269-stock-has-seen-strong-mom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0327786744.USD","LU0326950275.SGD","LU0359201612.USD","LU0348825331.USD","LU1242518857.USD","LU0819121731.USD","LU1242518931.SGD","BK1141","LU0140636845.USD","LU0516422440.USD","BK1576","LU1794554557.SGD","LU1880383366.USD","LU0979878070.USD","LU0456846285.SGD","LU0052750758.USD","BK1521","LU0456827905.SGD","LU0856984785.SGD","LU0043850808.USD","LU0708995583.HKD","LU0307460666.USD","LU1720050803.USD","LU2039709279.SGD","LU0359202008.SGD","02269","BK1610","LU0516423091.SGD","LU0823426480.USD","LU1688375341.USD","LU0348735423.USD","LU0039217434.USD","LU0181495838.USD","LU0572944931.SGD","LU0051755006.USD","LU0588546209.SGD","LU0417516902.SGD","BK1589","LU0516422366.SGD","SG9999002562.SGD","LU0823426308.USD","LU0417516738.SGD","IE00B0JY6N72.USD","LU0320764599.SGD","LU0516423174.USD","LU0516422952.EUR","SG9999002463.SGD"],"gpt_icon":0},{"id":"2513071291","title":"Greater China Stocks Slip; Taiwan Sees Largest Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2513071291","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513071291?lang=en_us&edition=full_marsco","pubTime":"2025-02-24 16:30","pubTimestamp":1740385800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Hong Kong's Hang Seng Index slipped 0.6% to 23341.61, and China's Shanghai Composite Index slipped 0.2% to 3373.03. The Taiwan Taiex index slipped 0.7% to 23565.31.Among Hang Seng constituents, WuXi AppTec Co. Ltd. posted the largest decline, dropping 10%, followed by shares of Wuxi Biologics  Inc., which dropped 9.0%. Shares of Kuaishou Technology dropped 5.6%.China Resources Mixc Lifestyle Services Ltd. was the biggest gainer among companies on the Hang Seng, surging 7.8%, and Longfor Group Holdings Ltd. surged 5.9%. Sands China Ltd. rounded out the top three movers on Monday, as shares surged 5.2%.Among large mainland China stocks, Beijing QingCloud Technology Group Co. Ltd. A posted the largest decline, dropping 15%, followed by shares of Shengyi Electronics Co. Ltd. A, which dropped 13%. Shares of UCloud Technology Co. Ltd. A dropped 13%.In Taiwan, Advanced Energy Solution Holding Co. Lt","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","01209","LU0251144936.SGD","688388","BK1610","LU0823426308.USD","81024","IE00B0JY6N72.USD","LU0326950275.SGD","01024","BK0214","LU0315179316.USD","LU0516422952.EUR","00960","LU0456827905.SGD","688183","BK1095","LU2097828714.EUR","BK0256","BK1583","LU0359202008.SGD","LU1794554557.SGD","688379","LU2097828631.EUR","SCHYY","02269","LU0708995583.HKD","LU0039217434.USD","688158","LU0516423091.SGD","LU0359201612.USD","LU1242518931.SGD","BK1521","LU0043850808.USD","BK1141","BK0231","LU0572944931.SGD","01928","BK1542","LU0979878070.USD","LU0307460666.USD","LU0348766576.USD","LU0417516902.SGD","BK1608","LU0823426480.USD","LU2097828474.EUR","688316","688165","LU0048597586.USD","BK1258"],"gpt_icon":1},{"id":"2512444415","title":"Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$30.59 From HK$19.30, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2512444415","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512444415?lang=en_us&edition=full_marsco","pubTime":"2025-02-20 16:57","pubTimestamp":1740041856,"startTime":"0","endTime":"0","summary":"Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$30.59 From HK$19.30, Keeps at Buy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02269","NMR"],"gpt_icon":0},{"id":"2511362452","title":"WuXi Biologics (Cayman) (HKG:2269) earnings and shareholder returns have been trending downwards for the last three years, but the stock ascends 9.4% this past week","url":"https://stock-news.laohu8.com/highlight/detail?id=2511362452","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511362452?lang=en_us&edition=full_marsco","pubTime":"2025-02-15 08:48","pubTimestamp":1739580522,"startTime":"0","endTime":"0","summary":"It is a pleasure to report that the WuXi Biologics (Cayman) Inc. ( HKG:2269 ) is up 55% in the last quarter. But that...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-hkg2269-earnings-and-shareholder-retur","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02269"],"gpt_icon":0},{"id":"2511637151","title":"China's Healthcare Sector Could Ride the AI Wave -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2511637151","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511637151?lang=en_us&edition=full_marsco","pubTime":"2025-02-14 15:13","pubTimestamp":1739517180,"startTime":"0","endTime":"0","summary":"0713 GMT - China's recent AI breakthrough could boost the efficiency of its healthcare sector and enable other potential novel services, Jefferies analyst Cui Cui says in an email. Chinese health-tech stocks are broadly higher in Hong Kong, with Alibaba Health Information up 25% and Ping An Health and Technology gaining 14%. Chinese contract drug makers WuXi AppTec and WuXi Biologics are 8.4% and 11% higher, respectively. Although these stocks aren't direct beneficiaries of the AI concept, they are likely rallying on their significant underweight positions and the fundamental shift in market sentiment after the Biosecure Act wasn't passed under the Biden administration, Cui adds. Her top industry picks in 2025 are WuXi Bio due to its better new order growth momentum and JD Health because of its AI development potential. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1105468828.SGD","LU0456846285.SGD","LU1720050803.USD","BK1591","BABA","IE00BFMHRM44.USD","BK1219","LU1823568750.SGD","LU0516422366.SGD","LU0310800965.SGD","LU0359201612.USD","LU0043850808.USD","BK1571","LU1880383366.USD","BK4554","LU1046421795.USD","02269","HCSG","BK4533","LU1048596156.SGD","BK4524","BK1515","LU0039217434.USD","LU0979878070.USD","LU1242518857.USD","LU1267930227.SGD","BK4575","LU0501845795.SGD","LU1051768304.USD","BK4565","BK1247","LU0516423174.USD","603259","LU0072913022.USD","IE00B0JY6N72.USD","BK4558","01833","BK1142","BK4504","LU2226246903.HKD","LU2488822045.USD","LU0588546209.SGD","BK4587","LU0819121731.USD","00241","SG9999002463.SGD","BK4548","09988","LU1515016050.SGD","LU1794554557.SGD"],"gpt_icon":1},{"id":"2510377814","title":"China hawk to be picked for key US Commerce Dept job, sources say","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377814","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510377814?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 22:04","pubTimestamp":1739369095,"startTime":"0","endTime":"0","summary":"China hawk to be picked for key US Commerce Dept job, sources sayBy Karen FreifeldFeb 12 (Reuters) - President Donald Trump plans to nominate Landon Heid, who served on the staff of the House of Repre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nL1N3P304W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","LU0326950275.SGD","LU1242518857.USD","LU1794554557.SGD","LU0516423091.SGD","LU2488822045.USD","BK1589","LU1242518931.SGD","LU1997245094.SGD","LU0417516902.SGD","LU0043850808.USD","LU0181495838.USD","LU0456842615.SGD","LU0823426480.USD","LU1880383366.USD","LU0819121731.USD","SG9999002463.SGD","LU0307460666.USD","BK0216","LU0456846285.SGD","LU0856984785.SGD","LU1688375341.USD","LU0572944931.SGD","LU0051755006.USD","LU0052750758.USD","LU0327786744.USD","LU0348825331.USD","LU1720050803.USD","LU1997245177.USD","LU0516422440.USD","LU0320764599.SGD","LU0588546209.SGD","LU0823426308.USD","LU0456827905.SGD","603259","LU0979878070.USD","LU0140636845.USD","LU0348735423.USD","LU0516422366.SGD","SG9999002562.SGD","IE00B0JY6N72.USD","LU0359202008.SGD","LU0516423174.USD","LU0417516738.SGD","BK1521","LU0359201612.USD","02269","BK1610","LU0039217434.USD","BK1141"],"gpt_icon":1},{"id":"1164667269","title":"Stock Track | Wuxi Biologics Soars 6.82% Intraday as UOB Kay Hian Upgrades to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=1164667269","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164667269?lang=en_us&edition=full_marsco","pubTime":"2025-02-04 16:06","pubTimestamp":1738656413,"startTime":"0","endTime":"0","summary":"Wuxi Biologics  shares surged 6.82% intraday on Tuesday, following an upgrade by UOB Kay Hian to a Buy rating from Sell. The investment firm also raised its price target for the biopharmaceutical company to HK$23.The stock's rally comes as analysts grow increasingly bullish on Wuxi Biologics' prospects. UOB Kay Hian's upgrade and higher price target suggest the firm sees significant upside potential for the company's shares in the near term.Positive analyst coverage and ratings often act as a ca","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Wuxi Biologics Soars 6.82% Intraday as UOB Kay Hian Upgrades to Buy","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02269"],"gpt_icon":0},{"id":"2508487135","title":"UOB Kay Hian Upgrades Wuxi Biologics to Buy from Sell, Price Target is HK$23","url":"https://stock-news.laohu8.com/highlight/detail?id=2508487135","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508487135?lang=en_us&edition=full_marsco","pubTime":"2025-02-04 16:02","pubTimestamp":1738656170,"startTime":"0","endTime":"0","summary":"UOB Kay Hian Upgrades Wuxi Biologics to Buy from Sell, Price Target is HK$23","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["U11.SI","02269"],"gpt_icon":0},{"id":"2506784668","title":"WuXi Biologics (Cayman) Inc.'s (HKG:2269) P/E Is On The Mark","url":"https://stock-news.laohu8.com/highlight/detail?id=2506784668","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506784668?lang=en_us&edition=full_marsco","pubTime":"2025-01-25 08:28","pubTimestamp":1737764885,"startTime":"0","endTime":"0","summary":"With a price-to-earnings (or \"P/E\") ratio of 26.4x WuXi Biologics (Cayman) Inc. ( HKG:2269 ) may be sending very...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-incs-hkg2269-pe-is-on-the-mark","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0181495838.USD","IE00B0JY6N72.USD","LU0588546209.SGD","LU0823426480.USD","LU0326950275.SGD","LU1242518857.USD","SG9999002562.SGD","BK1576","LU0359201612.USD","LU0856984785.SGD","LU0052750758.USD","LU0516422952.EUR","LU0417516738.SGD","LU0320764599.SGD","LU0359202008.SGD","LU0327786744.USD","LU0456846285.SGD","LU1688375341.USD","LU0979878070.USD","LU2039709279.SGD","BK1141","LU0516423174.USD","LU0572944931.SGD","LU1720050803.USD","LU0307460666.USD","LU0039217434.USD","02269","LU0348825331.USD","LU0456827905.SGD","LU0516422366.SGD","LU0823426308.USD","LU0516422440.USD","LU0516423091.SGD","LU1794554557.SGD","LU0348735423.USD","LU0140636845.USD","LU1242518931.SGD","BK1589","LU0417516902.SGD","LU1880383366.USD","LU0051755006.USD","LU0043850808.USD","LU0819121731.USD","SG9999002463.SGD","BK1610","BK1521","LU0708995583.HKD"],"gpt_icon":0},{"id":"2504250442","title":"Investor Confidence on WuXi Companies Seems Stronger -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2504250442","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504250442?lang=en_us&edition=full_marsco","pubTime":"2025-01-20 12:23","pubTimestamp":1737346980,"startTime":"0","endTime":"0","summary":"0423 GMT - Investor confidence in WuXi companies looks stronger ahead of Trump's inauguration, Daiwa analyst Wilfred Yuen says. After the proposed U.S. Biosecure Act, which restricts some Chinese biotech companies from doing business in the U.S., was not enacted under the Biden administration, investors are watching to see what the fate of the legislation or any potential successor will be under Trump, Yuen says. Trump's promise on Sunday to save social media app TikTok from being banned in the U.S. is giving some the impression that he may be more pragmatic in dealing with national security-related issues, he says. WuXi AppTec and WuXi Biologics also gave positive updates last week at a conference, confirming that fundamentals are intact, he adds. WuXi AppTec and WuXi Biologics' shares are up 7.3% and 5.4%, respectively, in Hong Kong. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0039217434.USD","LU0708995583.HKD","LU0043850808.USD","LU2039709279.SGD","SG9999002463.SGD","LU0307460666.USD","LU0819121731.USD","LU0516423174.USD","LU0516422440.USD","LU0856984785.SGD","LU0979878070.USD","LU0456827905.SGD","LU1242518931.SGD","LU0359202008.SGD","LU0823426480.USD","LU1880383366.USD","LU0326950275.SGD","BK1576","LU1794554557.SGD","LU0348825331.USD","LU0516423091.SGD","LU0320764599.SGD","LU2488822045.USD","BK1141","LU0572944931.SGD","LU0051755006.USD","LU0417516902.SGD","BK1521","LU0588546209.SGD","LU0052750758.USD","LU0359201612.USD","603259","LU1720050803.USD","LU0516422952.EUR","LU1997245177.USD","LU0181495838.USD","LU0456842615.SGD","LU0823426308.USD","SG9999002562.SGD","02269","LU1688375341.USD","LU0456846285.SGD","LU0417516738.SGD","LU0140636845.USD","LU0327786744.USD","LU0348735423.USD","BK1610","LU0516422366.SGD","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"2503730655","title":"BUZZ-China's WuXi XDC rises on robust results forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2503730655","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503730655?lang=en_us&edition=full_marsco","pubTime":"2025-01-15 10:37","pubTimestamp":1736908646,"startTime":"0","endTime":"0","summary":"BUZZ-China's WuXi XDC rises on robust results forecast** WuXi XDC Cayman 2268.HK rises 4.4% to HK$30.75; set for a second straight session of gains** Chinese antibody drug developer sees 2024 rev, net profit and adjusted net profit jumping more than 85%, 260% and 170% y/y, respectively, on demand from antibody drug conjugate and bioconjugate industries** Profit margin improving on high utilisation rate of co's production facilities; faster ramp-up of production lines also increases operating efficiency** Stock third biggest pct gainer on Hong Kong's healthcare index .HSCIH, which is down 0.7%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250115:nL1N3OB01S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348735423.USD","LU0051755006.USD","LU1880383366.USD","LU0588546209.SGD","LU0979878070.USD","SG9999002463.SGD","LU0326950275.SGD","LU0708995583.HKD","BK1141","SG9999002562.SGD","LU0823426480.USD","LU0327786744.USD","LU0856984785.SGD","LU1688375341.USD","LU1794554557.SGD","LU0456846285.SGD","IE00B0JY6N72.USD","LU2488822045.USD","LU0516422440.USD","LU0359202008.SGD","LU0417516902.SGD","SG9999014674.SGD","LU0320764599.SGD","LU0039217434.USD","LU0043850808.USD","LU0052750758.USD","LU0348825331.USD","LU1242518857.USD","BK1521","LU0456827905.SGD","BK1610","LU0516422952.EUR","LU0516423174.USD","LU0140636845.USD","LU0417516738.SGD","BK1589","LU2039709279.SGD","02268","LU1242518931.SGD","LU0181495838.USD","LU0516423091.SGD","LU0307460666.USD","LU0516422366.SGD","LU0819121731.USD","LU1720050803.USD","BK1576","02269","LU0359201612.USD","LU0572944931.SGD","LU0823426308.USD"],"gpt_icon":0},{"id":"2501292221","title":"China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2501292221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501292221?lang=en_us&edition=full_marsco","pubTime":"2025-01-07 16:23","pubTimestamp":1736238180,"startTime":"0","endTime":"0","summary":"0822 GMT - China's healthcare sector will likely get a significant boost from national policies in 1Q, Citi analysts write in a note. This year marks the start of the most positive structural change in the industry, as it will be the first time that China's public healthcare system is able to include commercial insurance providers as significant payers, they say. The brokerage recommends buying shares in companies that will be direct beneficiaries of the reform. These include pharmaceutical and biopharmaceutical firms, pharmaceutical distributors and medical device companies. Citi's top picks include Jiangsu Hengrui Medicine, Hansoh Pharmaceutical, SSY Group, Akeso, Sichuan Kelun-Biotech Biopharmaceutical, Mindray Medical, Sinopharm Group, WuXi AppTec, Wuxi Biologics and Gushengtang. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU0359202008.SGD","02273","LU0405327148.USD","LU0516422366.SGD","BK1574","LU0348784397.USD","06990","BK1589","LU0140636845.USD","LU0979878070.USD","BK0012","LU1064131003.USD","BK1583","BK1219","SHTDY","LU0039217434.USD","BK1576","BK1610","LU0348735423.USD","09926","LU1242518857.USD","HCSG","600276","603259","LU0516422952.EUR","LU0326950275.SGD","02269","IE00B543WZ88.USD","LU0052750758.USD","BK1191","01099","BK0196","LU1880383366.USD","LU0588546209.SGD","LU1997245094.SGD","BK4137","BK0188","LU0516423174.USD","LU0819121731.USD","02005","03692","LU0856984785.SGD","LU2460026573.USD","LU1328615791.USD","LU0516422440.USD","LU0196878994.USD","LU0640798160.USD","LU0359201612.USD","LU0348825331.USD"],"gpt_icon":0},{"id":"2501407228","title":"WuXi Biologics (Cayman) Subsidiary to Sell Vaccines Manufacturing Facility in Ireland for $500 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2501407228","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501407228?lang=en_us&edition=full_marsco","pubTime":"2025-01-07 15:14","pubTimestamp":1736234097,"startTime":"0","endTime":"0","summary":"WuXi Biologics   subsidiary WuXi Vaccines Ireland agreed to sell all the property and assets related to a vaccines manufacturing facility in Ireland to MSD International for $500 million, a Monday Hong Kong bourse filing said.The vaccine manufacturing facility is designed and constructed by the vendor for the purchaser and is located at IDA Science and Technology Park, Haynestown, Dundalk, Co. Louth, A91 A4CC, Ireland.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1242518931.SGD","SG9999002562.SGD","LU0181495838.USD","LU0588546209.SGD","LU0326950275.SGD","LU0417516738.SGD","LU0327786744.USD","LU0856984785.SGD","LU0456827905.SGD","LU1720050803.USD","LU0823426480.USD","LU0417516902.SGD","LU0516423174.USD","BK1521","LU0708995583.HKD","LU1880383366.USD","LU0307460666.USD","LU0052750758.USD","LU0348735423.USD","LU1794554557.SGD","LU0359202008.SGD","LU0043850808.USD","BK1589","LU0823426308.USD","LU0516422952.EUR","LU0819121731.USD","SG9999002463.SGD","LU0456846285.SGD","LU0140636845.USD","02269","BK1576","LU0039217434.USD","BK1141","LU0516423091.SGD","LU1688375341.USD","LU0051755006.USD","LU0348825331.USD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0516422440.USD","LU0572944931.SGD","LU0979878070.USD","LU1242518857.USD","BK1610","LU0359201612.USD","LU0320764599.SGD","LU0516422366.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":0.1284},{"period":"3month","weight":0.5456},{"period":"6month","weight":0.6771},{"period":"1year","weight":0.8741},{"period":"ytd","weight":0.5262}],"compareEarnings":[{"period":"1week","weight":-0.0111},{"period":"1month","weight":-0.0152},{"period":"3month","weight":0.1661},{"period":"6month","weight":0.1354},{"period":"1year","weight":0.4162},{"period":"ytd","weight":0.1678}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.037371},{"month":2,"riseRate":0.5,"avgChangeRate":-0.003108},{"month":3,"riseRate":0.625,"avgChangeRate":0.018761},{"month":4,"riseRate":0.428571,"avgChangeRate":0.021731},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011574},{"month":6,"riseRate":0.571429,"avgChangeRate":0.069801},{"month":7,"riseRate":0.625,"avgChangeRate":0.059733},{"month":8,"riseRate":0.5,"avgChangeRate":0.030152},{"month":9,"riseRate":0.625,"avgChangeRate":0.034087},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023256},{"month":11,"riseRate":0.5,"avgChangeRate":0.046185},{"month":12,"riseRate":0.5,"avgChangeRate":0.009183}],"exchange":"SEHK","name":"WUXI BIO","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WUXI BIO,02269,WUXI BIO股票,WUXI BIO股票老虎,WUXI BIO股票老虎国际,WUXI BIO行情,WUXI BIO股票行情,WUXI BIO股价,WUXI BIO股市,WUXI BIO股票价格,WUXI BIO股票交易,WUXI BIO股票购买,WUXI BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}